They only mimic what GLP-1 doestemporarilyand come with a long list of side effects like nausea, bloating, digestive issues, and even muscle loss
For clinicians, GLP-1based therapy has joined the toolkit for obesity in a way that demands attention and responsible use
In preclinical trials, rodents treated with Reta exhibited a marked reduction in food intake, often within days of starting treatment
Supplements designed for bariatric or GLP-1 support are often created with smaller appetites and reduced intake patterns in mind
This made it possible to discover peptides in low abundance, including hormone precursors and processing intermediates which could not be characterised by other means at the time
Early findings suggest GLP-1 may reduce inflammation in parts of the brain involved in memory